Skip to content
Maimon Research LLC

  • Home
  • Publications
  • Working Papers
  • WYOMING CERTIFICATE PROGRAM
  • Australian PBAC HTA Review
  • Wyoming PHCY 5141
Latest Working Papers

RASCH LATENT TRAIT POSSESSION AND RESPONSE TO THERAPY

November 21, 2024 Dr Paul Langely 18 Views

Paul C. Langley, Ph.D. , Adjunct Professor, Graduate School, College of Pharmacy, University of Minnesota, Minneapolis MN and School of Pharmacy, University of Wyoming, Laramie, WY

The Maimon Working Papers are free to download (in PDF format) at the bottom of the page.

Maimon Working Paper No 24 20 November 2024Download
  • RELATIVE DIFFERENCES AND THE MEASUREMENT SHAMBLES IN HEALTH TECHNOLOGY ASSESSMENT
  • THE IMPOSSIBLE TIME TRADE-OFF  TECHNIQUE

Key Links

  • Australian PBAC HTA Review
  • Publications 2017- 2023
  • Latest Working Papers
  • Nonsense on Stilts
  • Assumptions and Models
  • Fundamental Measurement
  • The Mystical Viral QALY
  • ICER Fantasy
  • Tufts' Ordinal Oversight
  • Cheers 22 Meets Catch 22
  • False Claims
  • Paper Mills
  • Rare Diseases
  • Rasch Value Claims
  • Morisky Adherence

Latest Publications

Langley PC. Nothing to Cheer About: Endorsing  Imaginary Economic Evaluations and Value Claims with CHEERS 22 [version 1; peer review: awaiting peer review]

Abstract

One of the more unfortunate features of health technology assessment is the tenacity with which leaders in the field and organizations such as the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the Institute for Clinical and Economic Review (ICER) cling to an evaluation framework that fails to meet the standards of normal science.

Copyright © 2024 Maimon Research LLC. All rights reserved.
Privacy Policy